In this study, we analyzed the prognostic relevance of specific cytogenetic abnormalities, IPSS-R cytogenetic classification and monosomal karyotype in the setting of HCT for MDS and AML post MDS.

Prognostic significance of neutrophil-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in myelodysplastic syndromes. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This ...

IPSS-M improved prognostic discrimination across all clinical end points with respect to IPSS-R (concordance was 0.81 v 0.74 for overall survival and 0.89 v 0.76 for leukemia-free survival, ...

Subgroup analyses showed consistently higher transfusion independence (TI) response rates than placebo across different risk groups regardless of International Prognostic Scoring System (IPSS), ...

The addition of CardioScore to IPSS-R resulted in upstaging for 12.5% (n = 12) patients and performed better for OS and TTP. Because molecular analysis is also used for MDS prognostication with the ...

A well-regarded tool for predicting prognosis in myelodysplastic syndromes is updated to incorporate mutations and tested with real-world data. An abstract and poster presented at the 2023 American ...

YARDVILLE, N.J., June 12, 2022 (GLOBE NEWSWIRE) -- Today, the MDS Foundation announced the development of a new prognostic scoring system, the IPSS-Molecular, that will significantly improve risk ...

The MDS Hub , run by Scientific Education Support (SES) in partnership with the European LeukemiaNet (ELN) , is an open-access online resource dedicated to providing balanced, reliable, and up-to-date ...

Sunday, Dec. 2, 2018, SAN DIEGO: At the American Society of Hematology (ASH) Annual Meeting, Cleveland Clinic medical hematologist and oncologist Aziz Nazha, M.D., will present results of a ...

Bristol Myers Squibb has announced positive topline results from its phase 3 trial of Reblozyl (luspatercept-aamt), the first erythroid maturation agent for first-line treatment of patients with very ...